Z. Perić

M. Aljurf, G. Basak, N. Chaudhri, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Improved outcome of patients with graft-versus-host disease after allogeneic hematopoietic cell transplantation for hematologic malignancies over time: an EBMT mega-file study

S. Montoto, N. Kröger, M. Robin, 2021, Haematologica.

Reduced Calcium Signaling Is Associated With Severe Graft-Versus-Host Disease: Results From Preclinical Models and From a Prospective EBMT Study

G. Basak, Z. Perić, H. Schoemans, 2020, Frontiers in Immunology.

How much has allogeneic stem cell transplant-related mortality improved since the 1980s? A retrospective analysis from the EBMT.

S. Montoto, N. Kröger, I. Yakoub-Agha, 2020, Blood advances.

Clinical and morphological practices in the diagnosis of transplant-associated microangiopathy: a study on behalf of Transplant Complications Working Party of the EBMT

K. Sułek, M. Aljurf, D. Niederwieser, 2018, Bone Marrow Transplantation.

Peripheral Blood Plasmacytoid Dendritic Cells at Day 100 Can Predict Outcome after Allogeneic Stem Cell Transplantation.

P. Chevallier, M. Mohty, M. Grégoire, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Early human cytomegalovirus reactivation is associated with lower incidence of relapse of myeloproliferative disorders after allogeneic hematopoietic stem cell transplantation

Z. Perić, N. Duraković, L. Desnica, 2018, Bone Marrow Transplantation.

Late Complications and Quality of Life after Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation.

P. Chevallier, M. Mohty, P. Moreau, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Features of EBV reactivation after reduced intensity conditioning unrelated umbilical cord blood transplantation

P. Chevallier, M. Mohty, P. Moreau, 2012, Bone Marrow Transplantation.

Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022

P. Pedrazzoli, I. Yakoub-Agha, M. Mohty, 2022, Bone Marrow Transplantation.

Features of Epstein-Barr Virus (EBV) reactivation after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation

P. Chevallier, M. Mohty, P. Moreau, 2011, Leukemia.

Allogeneic hematopoietic stem cell transplantation for adult patients with t(4;11)(q21;q23) KMT2A/AFF1 B-cell precursor acute lymphoblastic leukemia in first complete remission: impact of pretransplant measurable residual disease (MRD) status. An analysis from the Acute Leukemia Working Party of the

J. Esteve, R. Foà, M. Labopin, 2021, Leukemia.

Measurable residual disease (MRD) testing for acute leukemia in EBMT transplant centers: a survey on behalf of the ALWP of the EBMT

J. Esteve, F. Baron, M. Labopin, 2020, Bone Marrow Transplantation.

Variability of nutritional practices in peritransplant period after allogeneic hematopoietic stem cell transplantation: a survey by the Complications and Quality of Life Working Party of the EBMT

M. Aljurf, D. Greenfield, G. Basak, 2018, Bone Marrow Transplantation.

Posttransplant cyclophosphamide‐based anti–graft‐vs‐host disease prophylaxis in patients with acute lymphoblastic leukemia treated in complete remission with allogeneic hematopoietic cell transplantation from human leukocyte antigen‐mismatched unrelated donors versus haploidentical donors: A study o

M. Labopin, D. Blaise, A. Nagler, 2022, Cancer.

Underdiagnosed veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) as a major cause of multi-organ failure in acute leukemia transplant patients: an analysis from the EBMT Acute Leukemia Working Party

F. Baron, M. Labopin, A. Nagler, 2020, Bone Marrow Transplantation.

Total body irradiation plus fludarabine versus thiotepa, busulfan plus fludarabine as a myeloablative conditioning for adults with acute lymphoblastic leukemia treated with haploidentical hematopoietic cell transplantation. A study by the Acute Leukemia Working Party of the EBMT

M. Labopin, A. Nagler, M. Mohty, 2022, Bone Marrow Transplantation.

Comparison of reduced-intensity conditioning regimens in patients with acute lymphoblastic leukemia >45 years undergoing allogeneic stem cell transplantation—a retrospective study by the Acute Leukemia Working Party of EBMT

M. Labopin, A. Nagler, M. Mohty, 2020, Bone Marrow Transplantation.

Haploidentical vs. unrelated allogeneic stem cell transplantation for acute lymphoblastic leukemia in first complete remission: on behalf of the ALWP of the EBMT

N. Kröger, M. Labopin, P. Chevallier, 2019, Leukemia.

The first steps towards a diverse and inclusive EBMT: a position paper

S. Montoto, I. Yakoub-Agha, J. Snowden, 2022, Bone Marrow Transplantation.

Sexual function of adult long-term survivors and their partners after allogeneic hematopoietic cell transplantation in Europe (S-FAST): a study from the Transplant Complications Working Party and Nurses Group of the EBMT

D. Greenfield, J. Mooyaart, Z. Perić, 2022, Bone Marrow Transplantation.

Clinical practice recommendation on hematopoietic stem cell transplantation for acute myeloid leukemia patients with FLT3-internal tandem duplication: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

J. Esteve, H. Döhner, F. Baron, 2020, Haematologica.

Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow Transplantation

J. Esteve, F. Baron, M. Labopin, 2020, Bone Marrow Transplantation.

COVID19 in hematological patients and telemedicine: lessons learned across Europe and the US

Cesar J. Figueroa, Z. Perić, A. Mussetti, 2022, Current opinion in infectious diseases.

Bone marrow versus mobilized peripheral blood stem cell graft in T-cell-replete haploidentical transplantation in acute lymphoblastic leukemia

M. Labopin, D. Blaise, A. Nagler, 2020, Leukemia.

Post-thaw viability of cryopreserved hematopoietic progenitor cell grafts: does it matter?

Z. Perić, R. Vrhovac, I. Kardum-Skelin, 2010, Collegium antropologicum.

Impact of HDAC inhibitors on dendritic cell functions.

M. Mohty, M. Grégoire, Z. Perić, 2012, Experimental hematology.

Thiotepa and antithymocyte globulin-based conditioning prior to haploidentical transplantation with posttransplant cyclophosphamide in high-risk hematological malignancies

A. Vekhoff, M. Labopin, M. Mohty, 2019, Bone Marrow Transplantation.

Von Willebrand Factor and Factor VIII as potential biomarkers of chronic Graft-versus-Host Disease

M. Grce, R. Zadro, D. Pulanić, 2015 .

Outcome of T‐cell–replete haploidentical stem cell transplantation improves with time in adults with acute lymphoblastic leukemia: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

P. Chiusolo, M. Labopin, A. Nagler, 2021, Cancer.

High levels of FVIII and von Willebrand factor in chronic Graft-versus-Host Disease

R. Zadro, M. Milošević, D. Pulanić, 2019 .

Glycoprotein YKL-40: a novel biomarker of chronic graft-vs-host disease activity and severity?

M. Milošević, D. Pulanić, S. Pavletic, 2016, Croatian medical journal.

Use of busulfan in conditioning for allogeneic hematopoietic stem cell transplantation in adults: a survey by the Transplant Complications Working Party of the EBMT

S. Montoto, N. Kröger, J. Backman, 2019, Bone Marrow Transplantation.

Steroid-free first line treatment of moderate and severe chronic GVHD: a survey from the Transplant Complications Working Party of the EBMT

G. Basak, I. Moiseev, Z. Perić, 2022, Bone Marrow Transplantation.

B regulatory cells and monocyte subpopulations in patients with chronic graft-vs-host disease

R. Zadro, M. Milošević, D. Pulanić, 2021, Croatian medical journal.

Which questionnaires should we use to evaluate quality of life in patients with chronic graft-vs-host disease?

G. Basak, D. Pulanić, S. Pavletic, 2016, Croatian medical journal.

Practice patterns in chronic graft-versus-host disease patient management and patient reported outcome measures across the EBMT allogeneic transplantation network

M. Grce, H. Greinix, A. Barata, 2022, Bone Marrow Transplantation.

Development and validation of a disease risk stratification system for patients with haematological malignancies: a retrospective cohort study of the European Society for Blood and Marrow Transplantation registry.

S. Montoto, F. Baron, M. Perales, 2021, The Lancet. Haematology.

Hematopoietic cell transplantation and cellular therapies in Europe 2021. The second year of the SARS-CoV-2 pandemic. A Report from the EBMT Activity Survey

J. Snowden, H. Baldomero, J. Passweg, 2023, Bone Marrow Transplantation.

Complications of Autologous Stem Cell Transplantation in Multiple Myeloma: Results from the CALM Study

S. Montoto, S. Iacobelli, J. Sierra, 2022, Journal of clinical medicine.

Febrile Neutropenia Following Autologous Stem Cell Transplantation in Patients with Lymphoma

Z. Perić, R. Vrhovac, B. Jakšić, 2008 .

ATG or no ATG? – survey of clinical practice in EBMT centers on behalf of the Transplant Complications Working Party of EBMT

G. Basak, I. Moiseev, A. Piekarska, 2022, Bone Marrow Transplantation.

F. Baron, M. Labopin, A. Nagler, 2019, Bone Marrow Transplantation.

Fludarabine or cyclophosphamide in combination with total body irradiation as myeloablative conditioning prior to allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia: an analysis by the Acute Leukemia Working Party of the EBMT

J. Bourhis, M. Labopin, A. Nagler, 2023, Bone Marrow Transplantation.

Reduced 8-Gray Compared to Standard 12-Gray Total Body Irradiation for Allogeneic Transplantation in First Remission Acute Lymphoblastic Leukemia: A Study of the Acute Leukemia Working Party of the EBMT

A. Ganser, J. Bourhis, M. Labopin, 2023, HemaSphere.

Author reply

I. Aurer, S. Dotlić, I. Radman, 2018, Internal medicine journal (Print).

Prediction of Nonrelapse Mortality in Patients With Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia Receiving Allogeneic Stem Cell Transplantation With Posttransplantation Cyclophosphamide-based Graft Versus Host Disease Prophylaxis

M. Labopin, P. Chevallier, D. Blaise, 2023, HemaSphere.

Allogeneic stem-cell transplantation with sequential conditioning in adult patients with refractory or relapsed acute lymphoblastic leukemia: a report from the EBMT Acute Leukemia Working Party

N. Kröger, M. Labopin, A. Nagler, 2019, Bone Marrow Transplantation.

CNS Involvement at Initial Diagnosis and Risk of Relapse After Allogeneic HCT for Acute Lymphoblastic Leukemia in First Complete Remission

M. Labopin, P. Chevallier, I. Yakoub-Agha, 2022, HemaSphere.

Influence of pretransplant inflammatory bowel disease on the outcome of allogeneic hematopoietic stem cell transplantation: a matched-pair analysis study from the Transplant Complications Working Party (TCWP) of the EBMT

N. Kröger, C. Crawley, N. Russell, 2021, Bone Marrow Transplantation.

Immunoglobulin heavy/light chain analysis enhances the detection of residual disease and monitoring of multiple myeloma patients

B. Labar, I. Radman, D. Šegulja, 2015, Croatian medical journal.

Association of pre-existing comorbidities with outcome of allogeneic hematopoietic cell transplantation. A retrospective analysis from the EBMT

N. Kröger, I. Yakoub-Agha, M. Mohty, 2021, Bone Marrow Transplantation.

The Impact of Achieving Complete Remission Prior to Allogeneic Stem Cell Transplantation on Progression-Free Survival in Hodgkin Lymphoma

I. Aurer, Z. Perić, N. Duraković, 2021, Clinical hematology international.

High incidence of aseptic hip necrosis in Hodgkin lymphoma patients treated with escalated BEACOPP receiving methylprednisolone

I. Aurer, S. Dotlić, Z. Perić, 2018, Internal medicine journal.

Gut Colonization by Multidrug-Resistant Gram-Negative Bacteria Is an Independent Risk Factor for Development of Intestinal Acute Graft-versus-Host Disease.

J. Biliński, G. Basak, Z. Perić, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Retrospective Comparison between 12-Gray and 8-Gray Total Body Irradiation (TBI) before Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Lymphoblastic Leukemia in First Complete Remission

A. Ganser, J. Bourhis, N. Kröger, 2021, Blood.

Comparison of Branded and Generic Imatinib Plasma Concentrations in Patients With Chronic Myelogenous Leukemia: Unicentric Study.

R. Zadro, I. Radman, Z. Perić, 2016, Clinical lymphoma, myeloma & leukemia.

Impact of Gut Colonization by Antibiotic-Resistant Bacteria on the Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective, Single-Center Study.

W. Wiktor-Jedrzejczak, J. Biliński, G. Basak, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Non-Myelofibrosis Chronic Myeloproliferative Neoplasm Patients Show Better Seroconversion Rates after SARS-CoV-2 Vaccination Compared to Other Hematologic Diseases: A Multicentric Prospective Study of KroHem

I. Aurer, D. Pulanić, D. Šegulja, 2022, Biomedicines.

Sarcopenia among patients after allogeneic hematopoietic stem cell transplantation and the impact of chronic graft-versus-host disease

D. Vitali Čepo, D. Pulanić, S. Pavletic, 2020, Journal of Cancer Research and Clinical Oncology.

Frequency of lethal central nervous system neurotoxicity in patients undergoing allogeneic stem cell transplantation: a retrospective registry analysis

N. Kröger, D. Blaise, G. Basak, 2019, Bone Marrow Transplantation.

Incidence of Acute Graft-Versus-Host Disease and Survival after Allogeneic Hematopoietic Cell Transplantation over Time: A Study from the Transplant Complications and Chronic Malignancies Working Party of the EBMT

S. Montoto, M. Robin, I. Yakoub-Agha, 2018, Blood.

Febrile reaction after hematopoietic stem cell infusion is more frequent if no steroid premedicaton is given which results in more frequent use of antibiotics in early post-transplant phase

Z. Perić, N. Duraković, L. Desnica, 2021 .

An unusual presentation of Gaucher's disease: aortic valve fibrosis in a patient homozygous for a rare G377S mutation.

Z. Perić, R. Vrhovac, I. Kardum-Skelin, 2010, Collegium antropologicum.

Diffuse large B-cell lymphoma in patient after treatment of angioimmunoblastic T-cell lymphoma.

Z. Perić, R. Vrhovac, I. Kardum-Skelin, 2010, Collegium Antropologicum.

Total body irradiation versus busulfan based intermediate intensity conditioning for stem cell transplantation in ALL patients >45 years—a registry-based study by the Acute Leukemia Working Party of the EBMT

J. Bourhis, M. Labopin, P. Chevallier, 2023, Bone Marrow Transplantation.

Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT)

F. Baron, I. Yakoub-Agha, D. Blaise, 2023, Bone Marrow Transplantation.

PB1669 RISK FACTORS FOR THROMBOEMBOLISM IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA

I. Aurer, I. Radman, D. Pulanić, 2019, HemaSphere.

Liječenje akutne mijeloične leukemije alogeničnom transplantacijom koristeći smanjen intenzitet kondicioniranja – metoda rezervirana samo za starije osobe?

B. Labar, Z. Perić, R. Serventi-Seiwerth, 2011 .

Practice harmonization workshops of EBMT: an expert-based approach to generate practical and contemporary guidelines within the arena of hematopoietic cell transplantation and cellular therapy

I. Yakoub-Agha, J. Snowden, D. Mclornan, 2023, Bone Marrow Transplantation.

ECP versus ruxolitinib in steroid-refractory acute GVHD – a retrospective study by the EBMT transplant complications working party

J. Pérez-Simón, Z. Perić, Z. Ozkurt, 2023, Frontiers in Immunology.

Immune Effector Cell-Associated Hematotoxicity (ICAHT): EHA/EBMT Consensus Grading and Best Practice Recommendations.

R. Houot, M. Kersten, J. Gribben, 2023, Blood.

Current incidence, severity, and management of veno-occlusive disease/sinusoidal obstruction syndrome in adult allogeneic HSCT recipients: an EBMT Transplant Complications Working Party study

J. Bourhis, M. Mohty, U. Salmenniemi, 2023, Bone Marrow Transplantation.

Artificial intelligence methods to estimate overall mortality and non-relapse mortality following allogeneic HCT in the modern era: an EBMT-TCWP study.

U. Salmenniemi, E. Forcade, Z. Perić, 2023, Bone marrow transplantation.

International recommendations for screening and preventative practices for long-term survivors of transplantation and cellular therapy: a 2023 update.

N. Chaudhri, Z. Perić, N. Majhail, 2024, Bone marrow transplantation.

International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 Update

N. Chaudhri, Z. Perić, N. Majhail, 2023, Transplantation and cellular therapy.

Late Complications and Quality of Life after Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation.

P. Chevallier, M. Mohty, P. Moreau, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hematopoietic cell transplantation and cellular therapies in Europe 2022. CAR-T activity continues to grow; transplant activity has slowed: a report from the EBMT

H. Baldomero, Z. Perić, M. Hazenberg, 2024, Bone marrow transplantation.

PTCy versus ATG as graft-versus-host disease prophylaxis in mismatched unrelated stem cell transplantation

P. Dreger, Z. Perić, T. Gedde-Dahl, 2024, Blood cancer journal.

Understanding the Needs and Lived Experiences of Patients With Graft-Versus-Host Disease: Real-World European Public Social Media Listening Study

G. Basak, Z. Perić, Jyoti Chauhan, 2023, JMIR cancer.

Impact of the type of tyrosine kinase inhibitor (imatinib or dasatinib) used before allo-HCT on outcome of patients with Philadelphia-positive acute lymphoblastic leukemia. A study on behalf of the Acute Leukemia Working Party of the EBMT.

M. Labopin, M. Mohty, U. Salmenniemi, 2024, Transplantation and cellular therapy.

Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation.

M. Mohty, F. Bonifazi, Z. Perić, 2024, The Lancet. Haematology.

Posttransplant cyclophosphamide versus antithymocyte globulin in patients with acute lymphoblastic leukemia treated with allogeneic hematopoietic cell transplantation from matched unrelated donors: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplanta

M. Labopin, D. Blaise, A. Nagler, 2023, Cancer.

Severe cytopenia after CD19 CAR T-cell therapy: a retrospective study from the EBMT Transplant Complications Working Party

A. Ganser, P. Dreger, J. Passweg, 2022, Journal for ImmunoTherapy of Cancer.

Decrease of lethal infectious complications in the context of causes of death (COD) after hematopoietic cell transplantation: COD-2 and COD-1 study of the Infectious Diseases Working Party EBMT

I. Yakoub-Agha, M. Mohty, J. Snowden, 2023, Bone Marrow Transplantation.

Sexual health-related psychological and emotional life after allogeneic haematopoietic stem-cell transplantation.

Z. Perić, Tamim Alsuliman, Lugien Alasadi, 2024, The Lancet. Haematology.